Nicolas Duveau

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn’s Disease Patients Classified i2 on the Rutgeerts Score

Pauline Bayart, Nicolas Duveau, Maria Nachury et al. · Digestive Diseases and Sciences · 2016 · 44 citations

Rutgeerts Score, Gastroenterology, Pathology +6

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease

Claire Painchart, Séverine Brabant, Nicolas Duveau et al. · Digestive Diseases and Sciences · 2019 · 37 citations

Inflammation, Chronic Inflammatory Diseases, Allergy +8

Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

Lucas Guillo, B. Flachaire, Jérôme Avouac et al. · Digestive and Liver Disease · 2022 · 31 citations · Full text

Inflammation, Rheumatology, Anti-inflammatory +12

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A <scp>GETAID</scp> multicentre cohort study

Mathurin Fuméry, Antoine Defrance, Xavier Roblin et al. · Alimentary Pharmacology & Therapeutics · 2022 · 30 citations

Patients with Crohnʼs Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Loïc Guerbau, Romain Gérard, Nicolas Duveau et al. · Inflammatory Bowel Diseases · 2017 · 27 citations · Full text